Why in news?
- Data from the study showed that a single dose of the therapy was superior to the current standard of care in helping reduce the bleeding rate in patients with moderately severe to severe forms of haemophilia B.
What is Haemophilia?
- It is a medical condition, mostly inherited, in which the ability of blood to clot is severely reduced.
- This disease is caused by a mutation in one of the genes, that provides instructions for making the clotting factor proteins needed to form a blood clot.
- This change or mutation can prevent the clotting protein from working properly or to be missing altogether. These genes are located on the X chromosome.
- Men are more vulnerable to haemophilia than women. It is a rare disease where in about 1 in 10,000 people are born with it.
Q1) What are the types of haemophilia?
The main types of haemophilia include- Haemophilia A which happens because of the deficiency of clotting factor 8, Haemophilia B which happens because of the deficiency of clotting factor 9 and Haemophilia C, also known as Rosenthal syndrome occurs due to the deficiency of factor 11.
Source: Pfizer’s haemophilia B gene therapy succeeds in late-stage study
Last updated on Sep, 2026
→ UPSC 2027 Notification will be released on 13 January 2027 at upsconline.nic.in.
→ Check out the latest UPSC Syllabus here.
→ Download UPSC Model Answers for Mains 2026
→ UPSC Mains Question Paper 2026 is out now for Essay & GS Paper 1, 2, 3 & 4.
→ UPSC Calendar 2027 has been released.
→ Enroll in Vajiram & Ravi’s UPSC Mains Test Series 2027 for structured answer writing practice, expert evaluation, and exam-oriented feedback.
→ Join Vajiram & Ravi’s UPSC Mentorship Program 2027 for personalized guidance, strategy planning, and one-to-one support from experienced mentors.
→ Go through the UPSC Mains Previous Year Papers to enhance your preparation.
→ UPSC has released UPSC Toppers List 2025 with the Civil Services final result on its official website.
→ Also check Best UPSC Coaching in India








